{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T10:53:58Z","timestamp":1783335238678,"version":"3.54.6"},"reference-count":48,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.bbalip.2005.09.009","type":"journal-article","created":{"date-parts":[[2005,10,3]],"date-time":"2005-10-03T13:40:34Z","timestamp":1128346834000},"page":"130-137","source":"Crossref","is-referenced-by-count":20,"title":["Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate"],"prefix":"10.1016","volume":"1737","author":[{"given":"Vicent","family":"Ribas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Palomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Roglans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Rotllan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Fievet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tailleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Julve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Carles","family":"Laguna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Blanco-Vaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Carles","family":"Escol\u00e0-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2005.09.009_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00041433-199906000-00007","article-title":"Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis","volume":"10","author":"Fruchart","year":"1999","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2005.09.009_bib2","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1161\/01.CIR.98.19.2088","article-title":"Mechanism of action of fibrates on lipid and lipoprotein metabolism","volume":"98","author":"Staels","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2005.09.009_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5551\/jat1994.3.81","article-title":"Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects","volume":"3","author":"Auwerx","year":"1996","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.bbalip.2005.09.009_bib4","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.tips.2003.08.001","article-title":"Murine models to investigate pharmacological compounds acting as ligands of PPARs in dyslipidemia and atherosclerosis","volume":"24","author":"Tailleux","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbalip.2005.09.009_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1172\/JCI2673","article-title":"Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2","volume":"102","author":"Sullivan","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2005.09.009_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/emm.2002.67","article-title":"Fenofibrate regulates obesity and lipid metabolism with sexual dimorphism","volume":"34","author":"Yoon","year":"2002","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbalip.2005.09.009_bib7","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.metabol.2004.05.003","article-title":"Effects of fenofibrate on high-fat diet-induced body weight gain and adiposity in female C57BL\/6J mice","volume":"53","author":"Jeong","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.bbalip.2005.09.009_bib8","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1042\/bj20030105","article-title":"The peroxisome-proliferator-activated receptor alpha agonist ciprofibrate severely aggravates hypercholesterolaemia and accelerates the development of atherosclerosis in mice lacking apolipoprotein E","volume":"373","author":"Fu","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbalip.2005.09.009_bib9","doi-asserted-by":"crossref","first-page":"28662","DOI":"10.1074\/jbc.M403271200","article-title":"The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions","volume":"279","author":"Fu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2005.09.009_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0006-291X(03)00088-3","article-title":"Fenofibrate improves lipid metabolism and obesity in ovariectomized LDL receptor-null mice","volume":"302","author":"Yoon","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2005.09.009_bib11","doi-asserted-by":"crossref","first-page":"48051","DOI":"10.1074\/jbc.M206966200","article-title":"Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice","volume":"277","author":"Duez","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2005.09.009_bib12","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0022-2275(20)31499-1","article-title":"Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein","volume":"42","author":"Blanco-Vaca","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2005.09.009_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(01)00751-1","article-title":"Apolipoprotein A-II, HDL metabolism and atherosclerosis","volume":"164","author":"Tailleux","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2005.09.009_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00041433-200304000-00008","article-title":"Apolipoprotein A-II: beyond genetic associations with lipid disorders and insulin resistance","volume":"14","author":"Kalopissis","year":"2003","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2005.09.009_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00041433-200406000-00003","article-title":"Apolipoprotein A-II, genetic variation on chromosome 1q21\u2013q24, and disease susceptibility","volume":"15","author":"Martin-Campos","year":"2004","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2005.09.009_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1388-1981(00)00127-X","article-title":"Increased production of very-low-density lipoproteins in transgenic mice overexpressing human apolipoprotein A-II and fed with a high-fat diet","volume":"1488","author":"Julve","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2005.09.009_bib17","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0022-2275(20)33441-6","article-title":"Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia","volume":"41","author":"Escola-Gil","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2005.09.009_bib18","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.2337\/diabetes.50.12.2809","article-title":"PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance","volume":"50","author":"Guerre-Millo","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2005.09.009_bib19","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1172\/JCI11497","article-title":"PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice","volume":"107","author":"Tordjman","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2005.09.009_bib20","doi-asserted-by":"crossref","first-page":"6720","DOI":"10.1074\/jbc.271.12.6720","article-title":"Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II","volume":"271","author":"Marzal-Casacuberta","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2005.09.009_bib21","series-title":"Guide for the Care and Use of Laboratory Animals","first-page":"23","author":"Council","year":"1985"},{"key":"10.1016\/j.bbalip.2005.09.009_bib22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0022-2275(20)31685-0","article-title":"ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance","volume":"42","author":"Escola-Gil","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2005.09.009_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1172\/JCI0215748","article-title":"Increased ABCA1 activity protects against atherosclerosis","volume":"110","author":"Singaraja","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2005.09.009_bib24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1124\/jpet.302.1.232","article-title":"Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats","volume":"302","author":"Roglans","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"Pt. 3","key":"10.1016\/j.bbalip.2005.09.009_bib25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1042\/bj3280745","article-title":"Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent manner","volume":"328","author":"Jong","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbalip.2005.09.009_bib26","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.ATV.20.11.2453","article-title":"Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic mice","volume":"20","author":"Tailleux","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2005.09.009_bib27","doi-asserted-by":"crossref","first-page":"11564","DOI":"10.1074\/jbc.274.17.11564","article-title":"Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis","volume":"274","author":"Boisfer","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2005.09.009_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-2275(20)42239-4","article-title":"Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia","volume":"32","author":"Alaupovic","year":"1991","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2005.09.009_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0005-2760(87)90305-5","article-title":"Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes","volume":"920","author":"Wang","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2005.09.009_bib30","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1172\/JCI118687","article-title":"Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice","volume":"97","author":"Berthou","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2005.09.009_bib31","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.ATV.0000067702.22390.20","article-title":"Increased fecal bile acid excretion in transgenic mice with elevated expression of human phospholipid transfer protein","volume":"23","author":"Post","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2005.09.009_bib32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1432-1033.1995.tb20797.x","article-title":"Regulation of rat liver apolipoprotein A-I, apolipoprotein A-II and acyl-coenzyme A oxidase gene expression by fibrates and dietary fatty acids","volume":"232","author":"Berthou","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbalip.2005.09.009_bib33","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJM197811302992207","article-title":"Plasma high-density lipoproteins","volume":"299","author":"Tall","year":"1978","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2005.09.009_bib34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0022-2275(20)33893-1","article-title":"ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice","volume":"39","author":"Voyiaziakis","year":"1998","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2005.09.009_bib35","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1172\/JCI118118","article-title":"Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor","volume":"96","author":"Vu-Dac","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2005.09.009_bib36","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0022-2275(20)42003-6","article-title":"Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression","volume":"37","author":"Schoonjans","year":"1996","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2005.09.009_bib37","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1388-1981(01)00156-1","article-title":"Regulation of lipid metabolism and gene expression by fenofibrate in hamsters","volume":"1533","author":"Guo","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2005.09.009_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.mrfmmm.2003.12.019","article-title":"Profiling of hepatic gene expression in rats treated with fibric acid analogs","volume":"549","author":"Cornwell","year":"2004","journal-title":"Mutat. Res."},{"key":"10.1016\/j.bbalip.2005.09.009_bib39","doi-asserted-by":"crossref","first-page":"16638","DOI":"10.1074\/jbc.275.22.16638","article-title":"Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity","volume":"275","author":"Guerre-Millo","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2005.09.009_bib40","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1053\/meta.2001.24870","article-title":"Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat","volume":"50","author":"Dana","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.bbalip.2005.09.009_bib41","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1074\/jbc.M008809200","article-title":"Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil","volume":"276","author":"Dallongeville","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2005.09.009_bib42","doi-asserted-by":"crossref","first-page":"25841","DOI":"10.1074\/jbc.M101160200","article-title":"Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate","volume":"276","author":"Bouly","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2005.09.009_bib43","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1093\/nar\/26.10.2491","article-title":"Multiple parameters determine the specificity of transcriptional response by nuclear receptors HNF-4, ARP-1, PPAR, RAR and RXR through common response elements","volume":"26","author":"Nakshatri","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbalip.2005.09.009_bib44","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/er.2002-0012","article-title":"Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator","volume":"24","author":"Puigserver","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbalip.2005.09.009_bib45","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1074\/jbc.M407515200","article-title":"The gene encoding acyl-CoA-binding protein is subject to metabolic regulation by both sterol regulatory element-binding protein and peroxisome proliferator-activated receptor alpha in hepatocytes","volume":"280","author":"Sandberg","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2005.09.009_bib46","doi-asserted-by":"crossref","first-page":"16380","DOI":"10.1016\/S0021-9258(17)46234-X","article-title":"A polymorphism affecting apolipoprotein A-II translational efficiency determines high density lipoprotein size and composition","volume":"265","author":"Doolittle","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2005.09.009_bib47","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/01.ATV.15.3.306","article-title":"Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humans","volume":"15","author":"Ikewaki","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2005.09.009_bib48","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1194\/jlr.M200081-JLR200","article-title":"Mechanisms of HDL deficiency in mice overexpressing human apoA-II","volume":"43","author":"Julve","year":"2002","journal-title":"J. Lipid Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138819810500226X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138819810500226X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T05:50:28Z","timestamp":1626587428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138819810500226X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":48,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S138819810500226X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2005.09.009","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}